Aurexel Lifesciences
- Company typePrivate
- Founded-
- HeadquartersAskainen, Finland
- Headcount1–10
- GTM typeB2B
- OfferingServices
Aurexel Lifesciences firmographics
Firmographics- Name
- Aurexel Lifesciences
- Legal name
- Aurexel Life Sciences Ltd.
- Website
- https://aurexel.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Aurexel Lifesciences industry classification
Industry- Product category
- Scientific Writing Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Writing & Publications (Clinical/Safety/HEOR) (HLAGALAG)
- akta.pro secondary industry
- Nonclinical Study Management & Regulatory Writing (IND-enabling) (HLAGAFAN)
Keywords
Where Aurexel Lifesciences is headquartered
LocationHeadquarters
- HQ city
- Askainen
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
Aurexel Lifesciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Scientific Writing Services: Professional services revenue from scientific and medical writing for pharmaceutical and biotechnology clients. Services include manuscript development, study reports, scientific presentations, and investigator brochures. Revenue generated through project-based engagements with clients requiring specialized scientific communication.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Aurexel Lifesciences product offering
Product offeringCore offering
Aurexel Lifesciences provides scientific and medical writing services to the pharmaceutical and biotechnology industry, with deep specialization in oncology and preclinical/translational research. The firm is staffed by PhD-trained scientists who deliver publication support, preclinical expertise, project planning/monitoring, and expert consultation to drug developers and research organizations.
Product overview
Aurexel Lifesciences is a specialized scientific writing and consulting services company offering a unified portfolio of four interconnected service offerings for pharmaceutical and biotechnology companies. The core service is Scientific & Medical Writing, which develops publication-ready content from complex datasets. This is supported by Preclinical & Translational Support for study planning and execution, Planning & Monitoring for project oversight, and Expert Consultation for preclinical cancer research strategy. All services are delivered by PhD-trained scientists and are focused on oncology and preclinical research domains.
Differentiator
Problem solved
Functional benefit
Products and services
- Scientific & Medical Writing Scientific and medical writing support for pharmaceutical and biotechnology clients, including publication-oriented documents, manuscripts, and scientific communications related to oncology and preclinical research.
- Preclinical & Translational Expertise Subject-matter expertise in preclinical and translational research, provided to pharma and biotech sponsors to support evidence development, study design, and scientific content for oncology programs.
- Project Planning & Monitoring Planning and monitoring services for scientific/medical writing projects, supporting sponsors in scoping, scheduling, and tracking deliverables across preclinical and clinical communication programs.
- Expert Consultation & Insights Expert consultation services provided by PhD-trained scientists for pharmaceutical and biotechnology clients requiring specialized oncology or translational science insight.
Companies that use Aurexel Lifesciences
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles1 record
Aurexel Lifesciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Aurexel Lifesciences partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights3 records
Aurexel Lifesciences competitors and assessment
Company assessmentDirect peers
- MedThink Communications: Medical communications and scientific services agency supporting pharma clients with publications and scientific content — comparable boutique positioning to Aurexel.
- Oxford PharmaGenesis: Specialized medical communications and scientific writing agency serving pharma and biotech clients globally, with strong oncology and HEOR publications focus — directly comparable to Aurexel's oncology scientific writing niche.
- Health Interactions: Specialist medical communications agency providing scientific content development and publication support for pharma/biotech clients — comparable niche, scientist-led model to Aurexel.
- Trilogy Writing & Consulting: Specialized medical writing consultancy focused on clinical and regulatory documents for pharma/biotech sponsors — closely mirrors Aurexel's expert-driven, scientist-led scientific writing model.
- Complete HealthVizion (CHV): Specialized medical communications and scientific visualization agency serving pharma/biotech with publications and scientific content — comparable boutique positioning in the medical writing niche.
Broad incumbents
- Parexel International: Global CRO offering medical writing, regulatory writing, and clinical study report services to pharma/biotech sponsors — overlaps Aurexel's preclinical and scientific writing support at much greater scale.
- Envision Pharma Group: Established medical communications and publications planning firm serving pharma/biotech with scientific communications, including oncology content — comparable service line to Aurexel with broader technology-enabled offerings.
- Fishawack Health: Global medical communications agency with dedicated oncology and scientific communications practices — competes with Aurexel for the same pharma/biotech medical writing engagements at significantly larger scale.
- IQVIA (Medical Communications): Global CRO with a medical communications and scientific writing practice serving pharma/biotech across all therapeutic areas including oncology — competes with Aurexel on enterprise contracts at vastly larger scale.
- Cactus Communications (Cactus Life Sciences): Large scientific communications and medical writing provider with global delivery, serving pharma/biotech with manuscript, publication, and regulatory writing support — overlaps Aurexel's core medical writing offering but at much greater scale and breadth.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Aurexel Lifesciences social profiles
Digital presenceAurexel Lifesciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aurexel Lifesciences leadership team
Management profileNumber of profiles
Aurexel Lifesciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aurexel Lifesciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aurexel Lifesciences
What does Aurexel Lifesciences do?
Aurexel Lifesciences provides scientific and medical writing services to the pharmaceutical and biotechnology industry, with deep specialization in oncology and preclinical/translational research. The firm is staffed by PhD-trained scientists who deliver publication support, preclinical expertise, project planning/monitoring, and expert consultation to drug developers and research organizations.
Is Aurexel Lifesciences a public or private company?
Aurexel Lifesciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Aurexel Lifesciences founded?
Aurexel Lifesciences was founded in -1. It employs 1 to 10 people.
Where is Aurexel Lifesciences based?
Aurexel Lifesciences is headquartered in Askainen, Finland, in the Europe region.
How does Aurexel Lifesciences make money?
One revenue line is on record: scientific Writing Services.
Who are Aurexel Lifesciences's main competitors?
Direct peers on record are MedThink Communications, Oxford PharmaGenesis, Health Interactions, Trilogy Writing & Consulting and Complete HealthVizion (CHV). Broad incumbents are Parexel International, Envision Pharma Group, Fishawack Health, IQVIA (Medical Communications) and Cactus Communications (Cactus Life Sciences).
Does Aurexel Lifesciences have an API?
No public API is recorded for Aurexel Lifesciences.
What industry is Aurexel Lifesciences in?
Aurexel Lifesciences's product category is Scientific Writing Services. Its primary akta.pro industry code is HLAGALAG, Medical Writing & Publications (Clinical/Safety/HEOR), with a secondary code of HLAGAFAN, Nonclinical Study Management & Regulatory Writing (IND-enabling). Its NAICS code is 5417 and its SIC code is 8731.